Live Breaking News & Updates on Hepeng Shi

Stay updated with breaking news from Hepeng shi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avistone Biotechnology Closes Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

United States , Hepeng Shi , National Medical Products Administration , Avistone Biotechnology , Yanchuang Capital , Bain Capital ,

Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI

BEIJING, China (BUSINESS WIRE) Avistone Biotechnology Co., Ltd (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, today announced results from its China and US IND enabling nonclinical studies for ANS014004 (“ANS01”), a novel small-molecule type II c-M. ....

United States , Hepeng Shi , European Organisation For Research , Avistone Biotechnology Co Ltd , Avistone Biotechnology Co , American Association For Cancer Research , National Cancer Institute , American Association , Cancer Research , European Organisation , Massachusetts United ,

Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Hepeng Shi , Avistone Biotechnology Co Ltd , European Organisation For Research , Avistone Biotechnology Co , National Cancer Institute , American Association For Cancer Research , American Association , Cancer Research , European Organisation , Massachusetts United ,

Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital

Press release content from Business Wire. The AP news staff was not involved in its creation. ....

Hong Kong , Palo Alto , United States , Shan Fu , Jun Gao , Scott Lessne , Ricky Sun , David Liu , Katera Mujadidi , Jiaqi Zheng , Hongbo Lu , Hepeng Shi , China National Medical Products Administration , Bain Capital Life Sciences , Pearl Biotechnology Co , Investor Group , Avistone Pharmaceuticals , Vivo Capital , Bain Capital , Primavera Capital , Pearl Biotechnology , Breakthrough Therapy , National Medical Products Administration , Managing Partner , Greater China , Bain Capital Asia Private Equity ,

Vivo Capital, Bain Back Chinese Biotech Firm in $200 Million Fundraising

Chinese biotechnology firm Avistone Pharmaceuticals has raised over $200 million in a series A round led by Vivo Capital in one of the largest such deals for the sector. ....

United States , Hong Kong , Palo Alto , Hongbo Lu , Hepeng Shi , Avistone Pharmaceuticals , Zai Lab Ltd , Pearl Biotechnology Co , Sinovac Biotech Ltd , Bolt Biotherapeutics Inc , Vivo Capital , Bain Capital , Primavera Capital , Beijing Based Avistone , Pearl Biotechnology , Greater China , Chairman Hepeng Shi , Sinovac Biotech ,